CVS Health Corp vs Deutsche Bank AG — how do they compare? CVS Health Corp trades at $106.03 (market cap $135.12B), while Deutsche Bank AG trades at $35.81 (market cap $67.54B). The key difference: CVS Health Corp is far larger — about 2× Deutsche Bank AG's market cap, and Deutsche Bank AG pays the higher dividend (3.3%). Which is the better fit depends on your goals.
| CVS | DB | |
|---|---|---|
Market Cap | $135.12B | $67.54B |
Sector | Health | Financials |
52-Week High | $106.18 | $40.33 |
52-Week Low | $58.75 | $28.37 |
Enterprise Value | $201.66B | — |
Dividend Yield | 2.51% | 3.3% |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →